Table 2.
Procedural details | N = 259 |
---|---|
En bloc resection—no. (%) | 153 (59.1%) |
PD-stent—no. (%) | 206 (79.5%) |
CBD-stent—no. (%) | 94 (36.3%) |
Plastic | 67 (71.2%) |
FCSEMS | 24 (25.5%) |
Unknown | 4 (4.3%) |
Pathology after resection—no. (%) | |
LGD | 164 (63.3%) |
HGD | 40 (15.4%) |
Adenocarcinoma | 37 (14.3%) |
Other | 10 (3.9%) |
Normal | 4 (1.5%) |
Unknown | 4 (1.5%) |
Hospital stay (days)—median (IQR)a | 1 (1–2) |
CBD common bile duct, FCSEMS fully covered self-expandable metal stent, HGD high-grade dysplasia, LGD low-grade dysplasia, PD pancreatic duct
aMissing in 5 cases